Table 3

Postoperative survival and IMVD determined with an anti-CD34 or an anti-CD105 antibody

5-year survival rate (%) IMVD (CD34)5-year survival rate (%) IMVD (CD105)
LowerHigherPLowerHigherP
All patients71.5%63.7%0.13774.9%60.4%0.018
p-stage
 I86.4%72.2%0.02391.8%66.7%0.002
 II65.5%67.5%0.74072.1%54.9%0.104
 IIIa37.4%36.3%0.99431.1%46.7%0.157